Provided by Tiger Trade Technology Pte. Ltd.

Lexicon Pharmaceuticals

1.76
0.0000
Volume:3.32M
Turnover:5.78M
Market Cap:781.44M
PE:-11.09
High:1.78
Open:1.75
Low:1.70
Close:1.76
52wk High:2.68
52wk Low:1.10
Shares:444.00M
Float Shares:220.42M
Volume Ratio:1.65
T/O Rate:1.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1587
EPS(LYR):-0.1387
ROE:-40.21%
ROA:-14.32%
PB:4.48
PE(LYR):-12.69

Loading ...

Lexicon Pharmaceuticals: Buy Rating Reiterated as Value Catalysts Build; $6 Price Target Maintained

TIPRANKS
·
May 08

Lexicon Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Lexicon Q1 FY26 net loss narrows to $1 million; revenue rises to $21.1 million

Reuters
·
May 07

Lexicon Pharmaceuticals Q1 Sales $1.090M Miss $9.380M Estimate

Benzinga Earnings
·
May 07

BRIEF-Lexicon Pharmaceuticals Q1 EPS USD -0.01

Reuters
·
May 07

Lexicon Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Clinical Updates

GlobeNewswire
·
May 07

Lexicon Pharmaceuticals Secures New Hercules Term Loan Facility

TIPRANKS
·
May 07

Lexicon enters USD 100 million loan facility with Hercules Capital

Reuters
·
May 07

Lexicon Pharmaceuticals Inc expected to post a loss of 3 cents a share - Earnings Preview

Reuters
·
May 05

Lexicon Pharmaceuticals : Loan Facility Provides for an Initial Interest-Only Period of 18 Months, With Potential for Two Six-Month Extensions

THOMSON REUTERS
·
May 05

Lexicon Pharmaceuticals Announces $100 Million Loan Facility With Hercules Capital

THOMSON REUTERS
·
May 05

Lexicon Pharmaceuticals: Under Terms, Initial $55 Mln Tranche Will Be Used to Repay Existing Loan Facility With Oxford Finance

THOMSON REUTERS
·
May 05

Press Release: Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital

Dow Jones
·
May 05

Lexicon Pharmaceuticals shareholders approved increase in authorized common shares to 900 million

Reuters
·
May 01

Lexicon Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026

GlobeNewswire
·
Apr 30

Lexicon says Phase 2b data support pilavapadin 10 mg for Phase 3 DPNP trial

Reuters
·
Apr 17